0001628280-15-008472 Sample Contracts

par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Aerie Pharmaceuticals Inc • November 6th, 2015 • Biological products, (no disgnostic substances) • New York

Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“CF&Co”) (the “Agent”), as follows:

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.